Status:
COMPLETED
EVA Nexus Vitrectomy Device Field Observation Study
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Retina Disorder
Vitreous Disorder
Eligibility:
All Genders
18-90 years
Brief Summary
determine the safety and effectiveness of the device.
Detailed Description
To perform a field observation study using the newly developed EVA Nexus vitrectomy device. Patients that are scheduled for intra-ocular surgery regardless of the indication: * Vitrectomy surgery * ...
Eligibility Criteria
Inclusion
- Patients that are scheduled for intra-ocular surgery regardless of the indication:
- Vitrectomy surgery
- Cataract surgery
- Vitrectomy combined with cataract surgery
- In case of (combined) vitrectomy: primary or repeat vitrectomy
- General or retrobulbar anesthesia, the latter can be combined with sedation
- Patients aged ≥ 18 years
Exclusion
- Patients aged \< 18 years
Key Trial Info
Start Date :
May 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05229094
Start Date
May 22 2021
End Date
April 1 2022
Last Update
July 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Belgium, 3000